US 10980788
Therapy for treating malignancies
granted A61KA61K31/444A61K9/0053
Quick answer
US patent 10980788 (Therapy for treating malignancies) held by Agios Pharmaceuticals, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/444, A61K9/0053, A61K9/146, A61K9/2054